CoChat

The molecular and genetic basis of AD: The end of the beginning: The 2000 Wartenberg lecture

Rosenberg, Roger N. · 2000 · Neurology
Cited by 157

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

The Decade of the Brain—the 1990s—was a time of gains in our knowledge of the molecular and genetic basis of Alzheimer’s disease (AD).1-4 The momentum of discovery and depth of molecular information that developed during that time clearly leads one to predict that it is the end of the beginning of deciphering the pathogenesis of AD leading to effective therapy. Most cases of AD are sporadic; however, the molecular and genetic information of specific genes and other risk factors that cause the familial form of AD will shed light on the etiology of the much more abundant sporadic forms. About 10% of familial disease presents as an autosomal dominant mode of transmission. Epidemiologic studies indicate that about 30% of AD patients have a family history of disease in which at least one first-degree relative is affected. It is clear that early onset autosomal dominant AD is a heterogeneous set of disorders caused in separate families by different genetic mutations. Late-onset sporadic disease is the result of yet-to-be-discovered multiple environmental and genetic influences. In support of this view, only one-third of identical twins are concordant for AD, indicating that nongenetic—perhaps environmental—factors are important in the pathogenesis of AD. Mutations in the amyloid precursor protein gene ( APP ) on chromosome 21q, and the presenilin 1 and 2 genes ( PS1 , PS2 ) on chromosomes 14q and 1q, account for approximately one half of early-onset forms of autosomal dominant inherited disease. An additional locus on chromosome 12 has also been described. It is estimated that 50% of dominantly inherited disease remains yet to be mapped and genetically identified. Although the specific functions of the proteins coded by the APP and the PS1 and PS2 genes are only incompletely known, they share a common effect of abnormally processing APP, resulting in a 50% …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.54.11.2045

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 157

Metadata

Authors
Rosenberg, R. N.
Venue
Neurology
Published
2000-06-13
Volume
54
Issue
11
Pages
2045-2054
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2170888068
Cited by
157
References
25
FWCI
10.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The molecular and genetic basis of AD: The end of the beginning: The 2000 Wartenberg lecture. https://app.cochat.ai/papers/10.1212/wnl.54.11.2045
The paper
Rosenberg, R. N. (2000). The molecular and genetic basis of AD: The end of the beginning: The 2000 Wartenberg lecture. Neurology. https://doi.org/10.1212/wnl.54.11.2045

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.